Angstrom Pharmaceuticals, Inc.
11Patents
4Active
11Granted
35Portfolio score
Filing activity: Nov 12, 1996 → Mar 4, 2011 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7807621B2 | Anti-invasive and anti-angiogenic compositions | Human Necessities | 26 | Active |
| US6277818A | Cyclic peptide ligands that target urokinase plasminogen activator receptor | Human Necessities | 12 | Expired |
| US5994309A | Anti-invasive and anti-angiogenic compositions and methods | Human Necessities | 10 | Expired |
| US6514710B1 | Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor | Human Necessities | 10 | Expired |
| US8313914B2 | Compositions and methods for modulation of cell migration | Chemistry; Metallurgy | 5 | Active |
| US6896870B1 | Diagnostic probes and therapeutics targeting uPA and uPAR | Chemistry; Metallurgy | 5 | Expired |
| US6696416B1 | Anti-invasive and anti-angiogenic compositions | Human Necessities | 4 | Expired |
| US5942492A | Cyclic peptides that bind to urokinase-type plasminogen activator receptor | Human Necessities | 3 | Expired |
| US6936587B1 | Anti-invasive and anti-angiogenic compositions | Human Necessities | 2 | Expired |
| US8697629B2 | Modulation of intracellular signaling | Human Necessities | 0 | Active |
| US8110543B2 | Anti-invasive and anti-angiogenic compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.